Immunotech Biopharm (HKSE:06978) Price-to-Tangible-Book : 10.54 (As of Jun. 05, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Immunotech Biopharm Price-to-Tangible-Book?

As of today (2024-06-05), Immunotech Biopharm's share price is HK$2.95. Immunotech Biopharm's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$0.28. Hence, Immunotech Biopharm's Price to Tangible Book Ratio of today is 10.54.

The historical rank and industry rank for Immunotech Biopharm's Price-to-Tangible-Book or its related term are showing as below:

HKSE:06978' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.29 Med: 6.67 Max: 17.86
Current: 10.54

During the past 6 years, Immunotech Biopharm's highest Price to Tangible Book Ratio was 17.86. The lowest was 4.29. And the median was 6.67.

HKSE:06978's Price-to-Tangible-Book is ranked worse than
88.62% of 1221 companies
in the Biotechnology industry
Industry Median: 2.78 vs HKSE:06978: 10.54

A closely related ratio is called PB Ratio. As of today, Immunotech Biopharm's share price is HK$2.95. Immunotech Biopharm's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$0.37. Hence, Immunotech Biopharm's P/B Ratio of today is 7.99.

Immunotech Biopharm Price-to-Tangible-Book Historical Data

The historical data trend for Immunotech Biopharm's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunotech Biopharm Price-to-Tangible-Book Chart

Immunotech Biopharm Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

4.29

8.76

4.58

17.86

Immunotech Biopharm Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial						8.76	3.60	4.58	6.31	17.86

Competitive Comparison of Immunotech Biopharm's Price-to-Tangible-Book

For the Biotechnology subindustry, Immunotech Biopharm's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunotech Biopharm's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunotech Biopharm's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Immunotech Biopharm's Price-to-Tangible-Book falls into.

Immunotech Biopharm Price-to-Tangible-Book Calculation

Immunotech Biopharm's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.95	/	0.28
	=	10.54

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Immunotech Biopharm Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Immunotech Biopharm's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunotech Biopharm (HKSE:06978) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunotech Biopharm Ltd (HKSE:06978) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Kangding Street, 8th Floor, Block 1, Guosheng Technology Park, Beijing Economic-technological Development Area, Beijing, CHN, 100176

Website

http://www.eaal.net

Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

Executives

Jung Hyun Chul
Evodevo Ltd
Tian Jin He Yue Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Wu Naifeng	2501 Other
Yan Kaijing	2501 Other
Yan Xijun	2501 Other
Tian Shi Li Kong Gu Ji Tuan You Xian Gong Si	2501 Other
Tian Shi Li Yi Yao Ji Tuan Gu Fen You Xian Gong Si	2501 Other
Tian Jin Di Zhi Tou Zi Guan Li You Xian Gong Si	2501 Other
Tian Jin Fu Hua De Ke Ji Kai Fa You Xian Gong Si	2501 Other
Li Yunhui	2501 Other
Tian Jin Hong Xun Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Kang Shun Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Shan Zhen Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Shun Qi Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other

Immunotech Biopharm (HKSE:06978) Headlines

No Headlines